-
Nov 15, 2018- Neurostimulation of the dorsal root ganglion (DRG) can provide pain relief for patients battling chronic pain when previous treatment options were unsuccessful- Abbott's new DRG Invisible Trial System brings an intuitive, wireless approach to the temporary evaluation giving patients the full benefits of DRG therapy prior to permanent implant
-
Oct 25, 2018NEW ASSAYS EMPOWER CLINICIANS TO MORE QUICKLY MAKE THE RIGHT DIAGNOSIS AT THE POINT-OF-CARE AND PRESCRIBE THE RIGHT TREATMENT
-
Oct 19, 2018- Advanced heart failure patients who will live with their device for the rest of their life now have access to a heart pump backed by the industry's strongest long-term data- HeartMate 3 offers significant advancements for patients, including a pump designed to reduce complications while improving survival and quality of life
-
Oct 1, 2018- New features further enhance Abbott′s market leading sensor-based continuous glucose monitoring technology- System offers optional low and high glucose alarms for people with diabetes at no additional cost
-
Sep 26, 2018- Research shows adding Abbott's High Sensitive Troponin-I diagnostic test to doctors' existing standard of care can help more accurately determine a person's chances of a heart attack or other cardiac event potentially months to years in advance- Physicians now have a blood test that looks at a biomarker from the heart, so people can confidently take the appropriate lifestyle and medical steps needed to help prevent heart disease